Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-25-021049
Filing Date
2025-06-23
Accepted
2025-06-23 16:34:52
Documents
1
Period of Report
2025-06-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 11696
  Complete submission text file 0001437749-25-021049.txt   13106
Mailing Address 5300 MEMORIAL DRIVE HOUSTON TX 77007
Business Address
PICKER DONALD H (Reporting) CIK: 0001266800 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37758 | Film No.: 251065354

Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Issuer) CIK: 0001659617 (see all company filings)

EIN.: 474671997 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)